Wanbury Ltd says US FDA classified Tanuku API facility inspection as “Official Action Indicated” (OAI)
- The US FDA inspected the facility from July 13–17, 2026.
- Wanbury’s current assessment is that the classification will not affect business continuity or customer supplies of existing products.
- The company said it will continue working with the FDA and strengthening regulatory compliance and manufacturing practices.
